Nexgel, Inc.
NXGL- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001468929
No open-market purchases or sales by Nexgel, Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $293.0K in total; no superinvestor holds it.
Other share classesNXGLW
Q4 2021 vs. Q3 2021
How the institutions holding Nexgel, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 0 | 5 | +5 |
| Shares | 0 | 111.0K | +111.0K |
| Value | $0 | $289.0K | +$289.0K |
New holders (5)
Institutions that held Nexgel, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 61,412 | $160.0K | 0.00% |
| Altium Capital Management LP | 28,570 | $75.0K | 0.02% |
| Morgan Stanley | 15,900 | $41.0K | 0.00% |
| UBS Group AG | 5,034 | $13.0K | 0.00% |
| Royal Bank of Canada | 38 | $0 | 0.00% |
Sold out (0)
Institutions that held Nexgel, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
None.